What You Should Know: – FuturHealth, a leader in personalized weight-loss solutions launches its Custom Meal Plans. Designed to complement the growing popularity of GLP-1 medications, the new offering provides a comprehensive approach to…
Continue Reading
What You Should Know: – Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes…
Continue Reading
What You Should Know: – A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal. – The Virta Health…
Continue Reading
What You Should Know:
– Nestlé Health Science, a global leader in nutritional science, today announced the launch of glp-1nutrition.com, a web platform designed to support individuals on their weight management journey, particularly those using…
Continue Reading
What You Should Know:
– Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
– The multi-phase partnership focuses on developing…
Continue Reading
Top News
Stat reports that Alphabet’s Verily will pivot – for the second time in two years – by retiring its chronic disease management app Onduo and moving to a new one called Lightpath, which…
Continue Reading
Welcome to the May edition of Digital Health Digest!This month, we're spotlighting key developments in telehealth funding, weight loss programs, cybersecurity challenges, and advancements in wearable technology. Join us to explore how these innovations…
Continue Reading
What You Should Know:
– A new study suggests that a weekly treatment with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly reduce the risk of kidney failure and other complications in patients with…
Continue Reading
As the nation grapples with a GLP-1 shortage, Hims & Hers is looking to improve access by making compounded GLP-1s available on its platform starting at $199 a month, the company announced Monday.
The San…
Continue Reading
What You Should Know:
– Today, Twin Health announced it is extending its whole body digital twin AI platform, proven to help members achieve remission of type 2 diabetes and eliminate medications, to address the challenge of obesity and…
Continue Reading
